Status:
UNKNOWN
Biological Implications of the Overlapping Phenomenon Between Childhood Schizophrenia and Autism Spectrum Disorders-Heterogeneity Approach Rather Than Diagnostic Boundary
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Schizophrenia
Autism Spectrum Disorder
Eligibility:
All Genders
15-59 years
Brief Summary
Complex diseases such as schizophrenia and autism are heterogeneous in clinical presentation and etiology. This high heterogeneity constitutes the challenges for the clinical diagnosis and etiological...
Eligibility Criteria
Inclusion
- SZ group: schizophrenia onset earlier than 12 years old
- COS group: schizophrenia onset later than 12 years old
- ASD group: diagnosed with autism spectrum disorder without schizophrenia
- Dual group: diagnosed with ASD and SZ
Exclusion
- congenital disease
- major physical diseases
- neurodegenerative disorder
- chromosomal aberration
Key Trial Info
Start Date :
February 2 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT06063525
Start Date
February 2 2015
End Date
December 31 2024
Last Update
October 18 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.